Profitelligence Profitelligence · Filing Ledger Open TEM research →

Form 8-K · Current Report · Filed 2024-11-05

Tempus AI Announces Acquisition of Ambry Genetics

Tempus AI, Inc. has entered into a Securities Purchase Agreement to acquire Ambry Genetics Corporation for $375.0 million in cash and the issuance of 4,843,136 shares of Tempus AI's Class A common stock, subject to customary closing conditions. In connection with the acquisition, Tempus AI has entered into a debt commitment letter with affiliates of Ares Capital Corporation for a $100.0 million senior secured revolving credit facility and additional term loans totaling $200.0 million. The acquisition is expected to close in the first quarter of 2025.

Filer
Tempus AI Inc. TEM · NASDAQ
Filed
Accession
0001193125-24-251239
CIK
0001717115
Signal
Medium impactHealthcare

Items reported

Item 1.01

Entry into a Material Definitive Agreement

Securities Purchase Agreement
Item 3.02

Unregistered Sales of Equity Securities

PIPE Financing
Item 9.01

Financial Statements and Exhibits

Exhibits Furnished

Market reaction

Close before filing

$49.50

Next session

+15.1%

Since filing

-11.4%

Latest close

$43.87

What happened, not what will happen — closing prices around the filing date.

Precedent

Previous filings from TEM reporting the same item, with the next session's move:

Exhibits (1)

About Tempus AI Inc.

Tempus AI Inc. is a pioneering technology company specializing in the development and application of artificial intelligence solutions across various industries. Its primary function is to harness AI-driven insights to enhance operational efficiency and decision-making processes for enterprises. Tempus AI Inc. is at the forefront of integrating machine learning into sectors such as healthcare, finance, and logistics, where predictive data analytics can provide substantial competitive advantages. The company delivers bespoke AI platforms that enable organizations to streamline complex data sets into actionable intelligence. Its expertise extends to natural language processing and computer vision, offering comprehensive AI tools that drive innovation and efficiency. As a significant player in the tech market, Tempus AI Inc. contributes to setting industry standards for AI deployment, impacting how businesses leverage intelligent technology to improve outcomes and strategic planning. Founded with a mission to propel the development of intelligent systems, Tempus AI Inc. remains a vital contributor to the digital transformation of multiple industries, facilitating the transition towards a more data-driven future.

Exchange NASDAQ Industry Health Information Services Company website ↗

Never miss another TEM filing

Profitelligence watches EDGAR around the clock and alerts you within seconds.

Set up free alerts